- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 159-173 of
231 results
2014 Exhibit: Renier J Brentjens et al, A Phase I Trial for the Treatment of Chemo re...
Document
IPR2022-00853, No. 2014-58 Exhibit - Renier J Brentjens et al, A Phase I Trial for the Treatment of Chemo refractory Chronic Lymphocytic Leukemia with CD19 Targeted Autologous T Cells, 16 M...
|
|
Cite Document
2039 Exhibit: Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma W...
Document
IPR2022-00853, No. 2039-83 Exhibit - Cor HJ Lamers et al, Treatment of Metastatic Renal Cell Carcinoma With Autologous T Lymphocytes Genetically Retargeted Against Carbonic Anhydrase IX...
|
|
Cite Document
2026 Exhibit: Information Disclosure Statement Initialed by Examiner Feb 22, 2016...
Document
IPR2022-00853, No. 2026-70 Exhibit - Information Disclosure Statement Initialed by Examiner Feb 22, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2002 Exhibit: Denise Grady, An Immune System Trained to Kill Cancer, NY TIMES S...
Document
IPR2022-00853, No. 2002-46 Exhibit - Denise Grady, An Immune System Trained to Kill Cancer, NY TIMES Sept 12, 2011, httpswwwnytimescom20110913health13genehtml (P.T.A.B. Jul. 19, 20...
|
|
Cite Document
2033 Exhibit: Richard A Morgan et al, Case Report of a Serious Adverse Event Follo...
Document
IPR2022-00853, No. 2033-77 Exhibit - Richard A Morgan et al, Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Reco...
|
|
Cite Document
2013 Exhibit: Renier Brentjens et al, Treatment of chronic lymphocytic leukemia wit...
Document
IPR2022-00853, No. 2013-57 Exhibit - Renier Brentjens et al, Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells case report of an unforeseen adverse event ...
|
|
Cite Document
2027 Exhibit: Supplemental Information Disclosure Statement Initialed by Examine...
Document
IPR2022-00853, No. 2027-71 Exhibit - Supplemental Information Disclosure Statement Initialed by Examiner June 17, 2016, US Patent Application No 14,996,953 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2040 Exhibit: ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ern...
Document
IPR2022-00853, No. 2040-84 Exhibit - ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ernest Beutler Lecture and Prize, SCIENCEX Aug 27, 2012, httpssciencexcomwire news1...
|
|
Cite Document
2019 Exhibit: Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen R...
Document
IPR2022-00853, No. 2019-63 Exhibit - Stephan A Grupp et al, T Cells Engineered With A Chimeric Antigen Receptor CAR Targeting CD 19 CTL0l 9 Produce Significant In Vivo Proliferation, Comp...
|
|
Cite Document
2042 Exhibit: US Patent No 7,402,431
Document
IPR2022-00853, No. 2042-86 Exhibit - US Patent No 7,402,431 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
2040 Exhibit: ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ern...
Document
IPR2022-00853, No. 2040-84 Exhibit - ASH honors Bruce R Blazar, MD, and Carl H June, MD, with 2012 Ernest Beutler Lecture and Prize, SCIENCEX Aug 27, 2012, httpssciencexcomwire news1...
|
|
Cite Document
2038 Exhibit: Michael H Kershaw et al, A Phase I Study on Adoptive Immunotherap...
Document
IPR2022-00853, No. 2038-82 Exhibit - Michael H Kershaw et al, A Phase I Study on Adoptive Immunotherapy Using Gene Modified T Cells for Ovarian Cancer, 12 CLINICAL CANCER RSCH 6106...
|
|
Cite Document
2032 Exhibit: Michael C Jensen et al, Antitransgene Rejection Responses Contribu...
Document
IPR2022-00853, No. 2032-76 Exhibit - Michael C Jensen et al, Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20CD19 Specific Chimeric A...
|
|
Cite Document
2043 Exhibit: Cancer treatment myths Any truth to these common beliefs, MAYO C...
Document
IPR2022-00853, No. 2043-87 Exhibit - Cancer treatment myths Any truth to these common beliefs, MAYO CLINIC March 22, 2022, httpswwwmayoclinicorgdiseases conditionscancerin depthcan...
|
|
Cite Document
2016 Exhibit: Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Imm...
Document
IPR2022-00853, No. 2016-60 Exhibit - Jennifer Couzin Frankel, Breakthrough of the Year 2013 Cancer Immunotherapy, 342 SCI 1432 2013 (P.T.A.B. Jul. 19, 2022)
|
|
Cite Document
